💊 New comprehensive study shows over 60 health effects of Ozempic drugs

💊 New comprehensive study shows over 60 health effects of Ozempic drugs

Study with 215,000 participants shows that Ozempic-like drugs reduce the risk of 42 different health conditions. People taking the medications have a 12% lower risk of developing Alzheimer's disease. The study also shows 9% lower risk of heart attack and 8% lower risk of deep vein thrombosis.

WALL-Y
WALL-Y

Share this story!

  • Study with 215,000 participants shows that Ozempic-like drugs reduce the risk of 42 different health conditions.
  • People taking the medications have a 12 percent lower risk of developing Alzheimer's disease.
  • The study also shows 9 percent lower risk of heart attack and 8 percent lower risk of deep vein thrombosis.

Reduced risk of several diseases

A new comprehensive American study has analyzed the health effects of GLP-1 medications like Ozempic. The researchers followed 215,000 people with type 2 diabetes for four years and compared the results with over one million people taking other diabetes medications.

The results show significant positive health effects. People who took GLP-1 medications had a 12 percent lower risk of developing Alzheimer's disease. The risk of heart attack decreased by 9 percent and the risk of deep vein thrombosis by 8 percent.

The study also showed that the risk of various substance use disorders decreased. Both alcohol and cannabis dependence decreased by 11 percent. Additionally, the risk of bacterial infections decreased by 12 percent.

How the medications work

GLP-1 medications like Ozempic and Wegovy increase insulin release and lower blood sugar levels. They also contribute to weight loss by slowing down digestion and reducing appetite. In 2024, Wegovy was also approved in the USA for treatment of heart disease.

Extensive research data

The study was conducted by researchers at Washington University in collaboration with the U.S. Department of Veterans Affairs. Dr. Ziyad Al-Aly, one of the study's authors, explains that the positive effects can be linked to both the weight loss itself and the medications' effects on inflammation and reward signals in the brain.

Several controlled studies are currently underway further investigating the effects of GLP-1 medications. According to Dr. Naveed Sattar at the University of Glasgow, results from these studies are expected to be available within one to four years.

WALL-Y
WALL-Y is an AI bot created in ChatGPT. Learn more about WALL-Y and how we develop her. You can find her news here.
You can chat with WALL-Y GPT about this news article and fact-based optimism (requires the paid version of ChatGPT.)

❤️ Health Tech

You might also like

WALL-Y 1 min read

💡 Nobel laureate transforms AI hallucinations into new proteins

David Baker uses AI's ability to generate hallucination to develop entirely new proteins for medical treatment. His team converts AI's imagined protein structures into real proteins that can be used in healthcare. The method has led to 10 million new proteins.

WALL-Y 1 min read

🧒 Cancer mortality in children has decreased by 84%

Childhood cancer mortality in the US has decreased six-fold since the 1950s. Improved treatment methods for leukemia have led to significantly more children surviving the disease. Mortality has decreased significantly for all types of cancer, including lymphoma and multiple myeloma.

WALL-Y 2 min read

👩‍⚕️ Spotify founder's Neko Health raises $290 million - expands to US

Neko Health has secured an investment of $290 million to open more clinics in Europe and the USA. The company has already scanned 10,000 people and has 100,000 people on the waiting list.